
Please try another search
Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers process development and optimization, analytical, and scale-up services for small molecule drug products throughout the pre-clinical and clinical stage; and ton-scale manufacturing services for registered starting materials, advanced intermediates, and active pharmaceutical ingredients. It also engages in pre-formulation and formulation development; provision of chemical macromolecule contract development manufacture organization (CDMO) solutions for polypeptides, oligonucleotides, glycans, toxins-linkers and other macromolecules; biosynthesis solutions; biologics CDMO solutions for monoclonal antibodies and antibody-drug conjugates; and contract research organization solutions and messenger RNA solutions. In addition, the company is involved in development and drug product manufacturing; provision of pharmaceutical analysis and testing services; medical research and development; manufacturing, sale, and development of medicine raw materials and relevant products; sale of drug products; pharmaceuticals and chemical manufacturing; wholesaling and retailing of drugs; sale, import and export trade; information technology; technology development; and research and experimental development activities. The company was founded in 1998 and is headquartered in Tianjin, China.
Name | Age | Since | Title |
---|---|---|---|
Hao Hong | 69 | 2011 | Founder, Chairman & CEO |
Rui Yang | 47 | 2011 | Co-CEO & Executive Director |
Stephen L. Buchwald | - | - | Member of Scientific Advisory Board |
Seble Wagaw | - | - | Member of Scientific Advisory Board |
Kar Chung Lee | 43 | 2021 | Independent Non Executive Director |
Phil S. Baran | 48 | - | Member of Scientific Advisory Board |
Ye Song | 64 | 2011 | Non-Executive Director |
Shanshan Di | 38 | 2017 | Shareholder representative Supervisor |
Xinxin Zhi | 44 | 2011 | Chairman of the Supervisory Committee |
Ting Zhang | 39 | 2021 | Non-Executive Director |
Da Zhang | 43 | 2018 | CFO, COO, Senior VP & Executive Director |
Patricia Alred | - | - | Member of Scientific Advisory Board |
Nicholas Turner | - | - | Member of Scientific Advisory Board |
Martin Eastgate | - | - | Member of Scientific Advisory Board |
Jin-Quan Yu | - | - | Member of Scientific Advisory Board |
Xuejiao Sun | 42 | 2023 | Independent Non-Executive Director |
Xinyi Hou | 64 | 2024 | Independent Non-Executive Director |
Timothy F. Jamison | - | - | Member of Scientific Advisory Board |
Stephane Caron | - | - | Member of Scientific Advisory Board |
Scott May | - | - | Member of Scientific Advisory Board |
Jingyi Hou | 41 | 2021 | Employee Representative Supervisor |
Liang Hong | 51 | 2011 | Executive VP & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review